Tissue Sealing Agents and Hemostasis Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Advance Medical Solution (AMS) Group Plc, Baxter, Cohera Medical, Inc., CryoLife, Inc.

The market for Tissue Sealing Agents and Hemostasis was estimated to be worth $ 6.8 billion in 2021, and it is anticipated to increase to $ 10.9 million by 2027, with a CAGR of 7.9% during 2022 and 2027.

Tissue Sealing Agents and Hemostasis Market Overview

Hemostasis is a physiological process that preserves blood fluidity by preventing blood loss from the body. Clots occur during hemostasis as a result of the natural coagulation cascade being activated. However, severe blood loss that results from serious surgery or trauma cannot be prevented by the body's normal healing mechanisms. Hemostats and tissue sealing agents help in such circumstances by reducing blood loss and promoting wound healing. In order to reduce the risk associated with excessive bleeding during surgical procedures, hemostats and tissue sealing agents are being utilized more frequently. Additionally, severe bleeding can lead to postoperative issues such as drawn-out surgeries and insufficient blood levels in the body.

The rise in the number of injuries caused by sports and car accidents is predicted to fuel the growth and demand for hemostasis and tissue sealing agents. Additionally, it is anticipated that the growing elderly population with chronic diseases and the rise in gastrointestinal, cardiovascular, and pulmonary procedures would both contribute to the expansion of the global market from 2021 to 2028. Additionally, the market's expansion is probably going to be boosted by the technology's rapid developments and advantageous reimbursement. Additionally, one of the important variables anticipated to contribute to the increase in hospital preference among the people over other medical settings is the cost and simple accessibility of the necessary medical facilities. The increased use of hemostats products for blood loss prevention in various general as well as less invasive operations, as well as the preference for minimally invasive surgeries over other traditional procedures, are expected to provide substantial growth prospects for the hemostasis and tissue sealing agents market from 2021 to 2028.

Industry News and Updates

2021-07-29: Baxter Announces Acquisition of PerClot Polysaccharide Hemostatic System to Expand Advanced Surgery Portfolio--

Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced its Baxter Healthcare Corporation subsidiary has completed the acquisition of certain assets related to PerClot Polysaccharide Hemostatic System from CryoLife, Inc (NYSE:CRY) for up to $60.8 million, including $25 million paid upfront. The remainder will be paid out upon achievement of certain select milestones. The transaction reinforces Baxter’s strategy of acquiring products and technologies that both complement and augment the company’s leading portfolio across the hospital, including in the operating room.

What are the major Applications, Types and Regions for Tissue Sealing Agents and Hemostasis Market?

Market is segmented based on the type, applications, companies and regions.

By Type, it is segmented into

• Natural Tissue Sealants


• Synthetic Tissue Sealants


• Others

By Application, it is segmented into

• Academics


• Hospitals


• Laboratories


• Others

Tissue Sealing Agents and Hemostasis Market Regional Analysis

Because of the growing need for adhesives and sealants, North America will consume more hemostasis and tissue sealing agents until 2028. Diabetes, cardiovascular diseases, and cancer are more common in the area. Higher healthcare costs are a result of the rising number of sports-related injuries. The quick flood of innovative tissue sealing chemicals and products has been guided by the strong presence of a few key industry companies and knowledgeable experts. Other factors impacting the growth of the regional market include the increased requirement to treat a variety of bleeding problems and greater technical advancements.

Asia Pacific, on the other hand, is predicted to rise rapidly throughout the forecast period, owing to an increase in the number of surgical procedures as a result of increased medical tourism in emerging economies such as China, Singapore, and India. For instance, orthopedic surgery in China and other emerging nations are 75% more affordable than those carried out in the United States, according to a piece written by OrthoStreams, a privately held orthopedic equipment company. Over the course of the forecast period, an increase in traffic accidents in the Asia Pacific region that result in trauma admissions to emergency rooms also supports market expansion in the area.  According to the Ministry of Road Transport and Highways, Government of India, the total number of persons injured in road accidents in 2015 are 500,279. These are expected to aid in growth of the market.

• North America
  
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East & Africa
  
  
  • Latin America
  
  
  
  

The Tissue Sealing Agents and Hemostasis Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Tissue Sealing Agents and Hemostasis Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

What is our Tissue Sealing Agents and Hemostasis Market report scope?

Key Takeaways from this Tissue Sealing Agents and Hemostasis Market Report

• Evaluate Tissue Sealing Agents and Hemostasis market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.


• Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.


• Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.


• Analyze the sales and distribution channels across geographies to enhance top-line revenues.


• Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.


• Get a quick outlook on the Tissue Sealing Agents and Hemostasis market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.


• Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.

Frequently Asked Questions

What is the growth rate of Tissue Sealing Agents and Hemostasis Market?

The Tissue Sealing Agents and Hemostasis Market is growing at a CAGR of 7.9% over the next 5 years.

Who are the key players in Tissue Sealing Agents and Hemostasis Market?

Advance Medical Solution (AMS) Group Plc, Baxter, Cohera Medical, Inc., CryoLife, Inc., C.R. Bard, Inc., Johnson & Johnson Services, Inc., Integra LifeSciences Corporation, Pfizer, Inc., B Braun Medical, Inc., Biomet, Inc., Cohesion Technologies, Inc., Covidien Plc., HyperBranch Medical Technology., Integra Life Sciences Corporation, MIL Laboratories Pvt., Ltd., Smith & Nephew

What are the significant types of Tissue Sealing Agents and Hemostasis Market?

Natural Tissue Sealants, Synthetic Tissue Sealants, Others

What are the major end-use applications of Tissue Sealing Agents and Hemostasis Market?

Academics, Hospitals, Laboratories, Others

All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.